BackPURE Bioscience Overview
PURE Bioscience, Inc.

PURE Bioscience Return on Equity

Latest ROE for PURE Bioscience: 37.76% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

37.76%

Return on Equity

37.76%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

PURE Bioscience (PURE) FAQ

PURE Bioscience (PURE) currently reports a ROE of 37.76%. That is above the sector sector average of -5.68%. Use the charts on this page to explore PURE Bioscience's ROE history and peer comparisons.

PURE Bioscience's ROE of 37.76% is higher than the its sector sector average of -5.68%. That is roughly 764.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but PURE Bioscience's current 37.76% should be judged against industry norms (sector average: -5.68%) and against PURE's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 37.76%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.68%. From there, open related valuation or income-statement pages for PURE Bioscience, and consider following PURE for alerts when major investors trade the stock.